These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 25038328)

  • 1. Myeloperoxidase gene expression and cognitive functions in depression.
    Talarowska M; Szemraj J; Gałecki P
    Adv Med Sci; 2015 Mar; 60(1):1-5. PubMed ID: 25038328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manganese superoxide dismutase gene expression and cognitive functions in recurrent depressive disorder.
    Talarowska M; Orzechowska A; Szemraj J; Su KP; Maes M; Gałecki P
    Neuropsychobiology; 2014; 70(1):23-8. PubMed ID: 25171019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiol protein groups correlate with cognitive impairment in patients with recurrent depressive disorder.
    Gałecki P; Talarowska M; Bobińska K; Kowalczyk E; Gałecka E; Lewiński A
    Neuro Endocrinol Lett; 2013; 34(8):780-6. PubMed ID: 24522026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ASMT gene expression correlates with cognitive impairment in patients with recurrent depressive disorder.
    Talarowska M; Szemraj J; Zajączkowska M; Gałecki P
    Med Sci Monit; 2014 Jun; 20():905-12. PubMed ID: 24881886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of MMP genes in recurrent depressive disorders and cognitive functions.
    Bobińska K; Szemraj J; Gałecki P; Talarowska M
    Acta Neuropsychiatr; 2016 Aug; 28(4):221-31. PubMed ID: 26856768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum KIBRA mRNA and Protein Expression and Cognitive Functions in Depression.
    Talarowska M; Szemraj J; Kowalczyk M; Gałecki P
    Med Sci Monit; 2016 Jan; 22():152-60. PubMed ID: 26768155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there a link between TNF gene expression and cognitive deficits in depression?
    Bobińska K; Gałecka E; Szemraj J; Gałecki P; Talarowska M
    Acta Biochim Pol; 2017; 64(1):65-73. PubMed ID: 27991935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Emotional and language prosody and working memory in patients with depression].
    Talarowska M; Zajączkowska M; Gałecki P
    Pol Merkur Lekarski; 2015 May; 38(227):269-72. PubMed ID: 26039021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Auditory-verbal declarative and operating memory among patients suffering from depressive disorders - preliminary study.
    Talarowska M; Florkowski A; Zboralski K; Berent D; Wierzbiński P; Gałecki P
    Adv Med Sci; 2010; 55(2):317-27. PubMed ID: 21163755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide plasma concentration associated with cognitive impairment in patients with recurrent depressive disorder.
    Talarowska M; Gałecki P; Maes M; Orzechowska A; Chamielec M; Bartosz G; Kowalczyk E
    Neurosci Lett; 2012 Feb; 510(2):127-31. PubMed ID: 22273980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlations between working memory effectiveness and depression levels after pharmacological therapy].
    Talarowska M; Zboralski K; Gałecki P
    Psychiatr Pol; 2013; 47(2):255-67. PubMed ID: 23888759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms in the type I deiodinase gene and frontal function in recurrent depressive disorder.
    Gałecka E; Talarowska M; Orzechowska A; Górski P; Szemraj J
    Adv Med Sci; 2016 Sep; 61(2):198-202. PubMed ID: 26866568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Working memory impairment as a common component in recurrent depressive disorder and certain somatic diseases.
    Galecki P; Talarowska M; Moczulski D; Bobinska K; Opuchlik K; Galecka E; Florkowski A; Lewinski A
    Neuro Endocrinol Lett; 2013; 34(5):436-45. PubMed ID: 23922050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malondialdehyde plasma concentration correlates with declarative and working memory in patients with recurrent depressive disorder.
    Talarowska M; Gałecki P; Maes M; Gardner A; Chamielec M; Orzechowska A; Bobińska K; Kowalczyk E
    Mol Biol Rep; 2012 May; 39(5):5359-66. PubMed ID: 22170602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total antioxidant status correlates with cognitive impairment in patients with recurrent depressive disorder.
    Talarowska M; Gałecki P; Maes M; Bobińska K; Kowalczyk E
    Neurochem Res; 2012 Aug; 37(8):1761-7. PubMed ID: 22562440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Differences in cognitive functioning of men and women with a diagnosis of depression].
    Fitas A; Berent D; Talarowska M
    Pol Merkur Lekarski; 2010 Mar; 28(165):199-202. PubMed ID: 20815167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive functions and serum levels of brain-derived neurotrophic factor in patients with major depressive disorder.
    Oral E; Canpolat S; Yildirim S; Gulec M; Aliyev E; Aydin N
    Brain Res Bull; 2012 Aug; 88(5):454-9. PubMed ID: 22498307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of oxidative/nitrosative stress and inflammation on cognitive functions in patients with recurrent depressive disorders.
    Talarowska M; Bobińska K; Zajączkowska M; Su KP; Maes M; Gałecki P
    Med Sci Monit; 2014 Jan; 20():110-5. PubMed ID: 24457625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between cognitive performance and cortisol reaction to the DEX/CRH test in patients recovered from depression.
    Behnken A; Bellingrath S; Symanczik JP; Rieck MJ; Zavorotnyy M; Domschke K; Arolt V; Zwanzger P
    Psychoneuroendocrinology; 2013 Mar; 38(3):447-54. PubMed ID: 22840287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.